Cantourage Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
HIGH
- Investments
-
2
- Share Price
-
$4.89
- (As of Friday Closing)
Cantourage General Information
Description
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
Contact Information
Website
www.cantourage.comCorporate Office
- Feurigstrasse 54
- 10827 Berlin
- Germany
Corporate Office
- Feurigstrasse 54
- 10827 Berlin
- Germany
Cantourage Stock Performance
As of 13-Nov-2026, Cantourage’s stock price is $4.89. Its current market cap is $63.5M with 13M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.89 | $5.35 | $2.46 - $7.91 | $63.5M | 13M | 0.28 |
Cantourage Financials Summary
As of 31-Dec-2024, Cantourage has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 64,208 | 64,208 | ||
| Revenue | 25,490 | 634 | ||
| EBITDA | (275) | |||
| Net Income | (4,623) | 9 | ||
| Total Assets | 18,041 | 18,041 | 48,834 | 48,027 |
| Total Debt | 0 | 0 |
Cantourage Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cantourage Signals
Cantourage Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cantourage Investments & Acquisitions (2)
Cantourage’s most recent deal was a Merger/Acquisition with SUMO Cannabis. The deal was made on 10-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SUMO Cannabis | 10-Aug-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Cantourage UK | 20-Jan-2021 | Joint Venture | Distributors (Healthcare) |
Cantourage ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Diversified Financials
Industry
Rank
Percentile
Asset Management and Custody Services
Subindustry
Rank
Percentile
Cantourage Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cantourage Holdings | London, United Kingdom | 2021 | |
| SUMO Cannabis | Trois-Rivieres, Canada | 2019 |
Cantourage FAQs
-
When was Cantourage founded?
Cantourage was founded in 2019.
-
Where is Cantourage headquartered?
Cantourage is headquartered in Berlin, Germany.
-
What is the size of Cantourage?
Cantourage has 7 total employees.
-
What industry is Cantourage in?
Cantourage’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Cantourage a private or public company?
Cantourage is a Public company.
-
What is Cantourage’s stock symbol?
The ticker symbol for Cantourage is HIGH.
-
What is the current stock price of Cantourage?
As of 13-Nov-2026 the stock price of Cantourage is $4.89.
-
What is the current market cap of Cantourage?
The current market capitalization of Cantourage is $63.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process